Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Paracetamol 2000 mg Twice Daily (BID)	235
Overall Study	STARTED	Paracetamol 1330 mg Thrice Daily (TID)	236
Overall Study	STARTED	Placebo	237
Overall Study	Safety Population	Paracetamol 2000 mg Twice Daily (BID)	234
Overall Study	Safety Population	Paracetamol 1330 mg Thrice Daily (TID)	236
Overall Study	Safety Population	Placebo	237
Overall Study	COMPLETED	Paracetamol 2000 mg Twice Daily (BID)	200
Overall Study	COMPLETED	Paracetamol 1330 mg Thrice Daily (TID)	193
Overall Study	COMPLETED	Placebo	196
Overall Study	NOT COMPLETED	Paracetamol 2000 mg Twice Daily (BID)	35
Overall Study	NOT COMPLETED	Paracetamol 1330 mg Thrice Daily (TID)	43
Overall Study	NOT COMPLETED	Placebo	41

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02311881/flow